Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

CA-125 in Screening Patients at High Risk for Ovarian Cancer

NCT00080639 ·Status: WITHDRAWN

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

NCT00086567 ·Status: COMPLETED

Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

NCT06775470 ·Status: RECRUITING

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

NCT00043472 ·Status: COMPLETED

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

NCT01074398 ·Status: UNKNOWN

Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.

NCT02341118 ·Status: TERMINATED

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

NCT00238342 ·Status: UNKNOWN ·Phase: NA

A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

NCT04487405 ·Status: TERMINATED

New Biomarkers Evaluating Ovarian Cancer

NCT01466049 ·Status: COMPLETED

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814 ·Status: COMPLETED

Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

NCT03691012 ·Status: UNKNOWN

Screening Women at High Genetic Risk for Ovarian Cancer

NCT00033488 ·Status: COMPLETED ·Phase: NA

Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00897806 ·Status: TERMINATED

Study of Circulating Tumoral DNA in Ovarian Cancer

NCT01350908 ·Status: COMPLETED ·Phase: NA

Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function

NCT00525460 ·Status: COMPLETED

DNA Single Nucleotide Polymorphisms as Predictors of Toxicity

NCT02478476 ·Status: UNKNOWN

Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

NCT00757263 ·Status: UNKNOWN

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype

NCT05574673 ·Status: RECRUITING

Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary

NCT00626873 ·Status: COMPLETED ·Phase: PHASE1

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

NCT03367260 ·Status: COMPLETED

Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

NCT07039552 ·Status: RECRUITING

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

NCT02406235 ·Status: COMPLETED

Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario

NCT06836219 ·Status: RECRUITING

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

NCT01445275 ·Status: WITHDRAWN

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

NCT06366997 ·Status: COMPLETED